GoodRx Care AI Market Strategy Report - Online Pharmacies

Answer Capsule

GoodRx Care entered the LLM Authority Index Online Pharmacies benchmark in September 2026 at 16.5% valid recommendation coverage, the highest first-month entry of any brand tracked this period. The brand holds 31.1% raw mention presence and a 9.2% top-three recommendation rate, but converts to a rank-one recommendation in only 3.0% of qualified observations. Its clearest strength is a 0.765 net sentiment score and a 29.2% top-three rate on Copilot, where it is the second-strongest brand in the category. Its clearest gap is rank-one placement: Amazon Pharmacy holds rank-one in 21.3% of observations against GoodRx Care's 3.0%, and the benchmark's Pricing & Value and Multi-Brand Comparison clusters carry zero qualified observations, leaving the brand's cost-oriented positioning unmeasured at the benchmark level.

Who This Report Is For

This report is for pharmacy, telehealth, and consumer healthcare leaders evaluating how GoodRx Care appears in AI-generated recommendations, and for teams responsible for category discovery, shortlist eligibility, and competitive positioning in AI-led pharmacy search.

Report Card

Executive Summary

GoodRx Care entered the September 2026 LLM Authority Index Online Pharmacies benchmark as a newly tracked brand entity at 16.5% valid recommendation coverage, placing sixth of ten tracked brands. The entry follows the benchmark's decision to split GoodRx and Optum Rx into service-line entities, with GoodRx Care and Optum entering tracking in September while the parent brands moved to 0.0%. The benchmark treats this as an instrument change, not a loss of AI recommendation favor, and the two series are not directly comparable.

The brand's raw mention presence of 31.1% is nearly double its valid recommendation coverage of 16.5%, a gap that indicates GoodRx Care is frequently referenced in AI answers without being shortlisted as a recommended option. Across 643 qualified observations, the brand recorded 155 positive mentions, 43 neutral mentions, and 2 negative mentions, producing a net sentiment score of 0.765. That framing quality is the second-highest among the category's higher-coverage brands and suggests the reference layer is favorable even where recommendation conversion lags.

Recommendation placement is where the gap widens. GoodRx Care holds a top-three position in 9.2% of qualified observations and rank-one in 3.0%, with 59 top-three recommendations and 19 rank-one recommendations. Amazon Pharmacy, by contrast, holds rank-one in 21.3% of observations. The brand's average recommended rank of 2.76 places it mid-list among brands that receive rank credit, ahead of CVS Pharmacy at 2.91 and Walgreens at 3.60, but well behind Amazon Pharmacy at 1.78.

The strongest platform signal is Copilot. GoodRx Care records a 29.2% top-three rate and a 12.5% rank-one rate on Copilot, with 36 valid recommendations across 72 observations, a 50.0% valid recommendation coverage rate on that surface. That is the highest Copilot coverage of any tracked brand except Amazon Pharmacy at 72.2%, and it exceeds CVS Pharmacy's 22.2% on the same surface. The brand's Copilot captured share of AI opportunity is 19.3%, its strongest platform result by a wide margin.

The clearest platform gap is Perplexity. GoodRx Care records a 6.6% top-three rate and a 0.0% rank-one rate on Perplexity across 61 observations, with 5 valid recommendations and no first-position placements. Gemini is similarly thin at a 3.4% top-three rate and a 3.4% rank-one rate across 88 observations. Both surfaces represent recommendation-stage visibility the brand has not yet converted.

The benchmark's cluster structure limits what can be concluded about GoodRx Care's cost-oriented positioning. All 643 qualified September observations fell into the Brand Recommendation cluster, and the Pricing & Value and Multi-Brand Comparison clusters carry zero qualified observations in both July and September 2026. The commercial question of which pharmacy wins on price and which wins in direct head-to-head comparison cannot be answered at the benchmark level and requires company-level prompt analysis.

What GoodRx Care Is Winning

Questions This Section Answers

• Where does GoodRx Care perform strongest across AI platforms?
• Why is the brand's framing quality considered a notable win despite lower presence than some competitors?

GoodRx Care's strongest evidence-backed win is its Copilot performance. The brand holds a 29.2% top-three rate and a 12.5% rank-one rate on Copilot, with 36 valid recommendations across 72 observations. Its 50.0% valid recommendation coverage on that surface is the second-highest in the tracked set, behind only Amazon Pharmacy. Copilot also produces the brand's highest captured share of AI opportunity at 19.3%, well above its category-wide figure of 4.9%.

The brand's second win is framing quality. A net sentiment score of 0.765 across 200 mentions, with only 2 negative mentions recorded, places GoodRx Care among the most favorably framed brands in the category. Honeybee Health at 0.916 and PillPack at 0.909 score higher, but both carry substantially lower presence. Among brands with meaningful presence, GoodRx Care's framing is strong.

The third win is first-month entry strength. GoodRx Care's 16.5% valid recommendation coverage is the highest debut recorded in the September benchmark, and it places the brand ahead of Honeybee Health, PillPack, Optum, and Capsule on coverage despite those brands having longer tracking histories. The brand also holds a 9.2% top-three rate that exceeds Walgreens at 8.1% and PillPack at 8.9%, despite far lower raw presence.

These wins are real but narrow. The brand does not lead the category on any benchmark-wide metric, and its rank-one rate of 3.0% remains well below the category leader.

Where GoodRx Care Has the Clearest AI Visibility Gaps

Questions This Section Answers

• Why does GoodRx Care get shortlisted in AI answers but rarely named first?
• Which platforms show the thinnest recommendation footprint for GoodRx Care?
• What does the absence of pricing and comparison cluster data mean for measuring the brand's cost positioning?

The clearest gap is rank-one conversion. GoodRx Care appears in a recommendation-shaped answer in 16.5% of qualified observations but is named first in only 3.0%. Amazon Pharmacy converts 45.6% coverage into 21.3% rank-one placement, a ratio of roughly one rank-one result for every two recommendations. GoodRx Care converts 16.5% coverage into 3.0% rank-one placement, a ratio closer to one in five. The brand is being shortlisted without being chosen first.

The second gap is Perplexity. Across 61 qualified observations on that surface, GoodRx Care records 5 valid recommendations, a 6.6% top-three rate, and zero rank-one placements. Its Perplexity captured share of AI opportunity is 1.6%, compared with 19.3% on Copilot and 5.5% on Google AI Overviews. Perplexity is the surface where the brand's recommendation footprint is thinnest relative to its category-wide position.

The third gap is Gemini. GoodRx Care holds a 3.4% top-three rate and a 3.4% rank-one rate across 88 Gemini observations, with 6 valid recommendations. Its Gemini captured share of AI opportunity is 0.9%, the lowest of its six tracked surfaces. The brand's Gemini presence rate of 19.3% is also its lowest across surfaces, indicating both limited reference and limited recommendation on that platform.

The fourth gap is the absence of comparison and pricing evidence. The benchmark's Multi-Brand Comparison and Pricing & Value clusters carry zero qualified observations in September 2026, meaning the brand's cost-oriented positioning is not measured in the public series. Competitors with broader service-line footprints, particularly Amazon Pharmacy and CVS Pharmacy, hold recommendation coverage that spans the full Brand Recommendation cluster. GoodRx Care's coverage is concentrated in a single cluster with no visibility into how it performs when AI systems compare options directly.

Biggest Opportunity

Questions This Section Answers

• Which two AI platforms offer the clearest path from reference presence to rank-one recommendations?
• How large is the gap between GoodRx Care's rank-one rate on Copilot and its category-wide rank-one rate?

The single clearest opportunity is converting GoodRx Care's existing reference presence into first-position recommendations on Copilot and Google AI Mode, the two surfaces where the brand already holds meaningful recommendation coverage. Copilot produces a 12.5% rank-one rate and Google AI Mode produces a 1.2% rank-one rate, against a category-wide rank-one rate of 3.0%. The gap between the brand's Copilot rank-one performance and its category-wide rank-one performance shows that first-position placement is achievable on at least one surface. Extending that pattern to Google AI Mode, where the brand holds 24 valid recommendations but only 2 rank-one placements, is the most direct path from reference to recommendation.

Competitive Landscape

Questions This Section Answers

• How does GoodRx Care's top-three and rank-one rate compare with Amazon Pharmacy and the rest of the tracked set?
• Where does GoodRx Care rank on average recommended placement among all tracked brands?

Amazon Pharmacy holds dominant recommendation power in the category, with a 30.5% top-three rate and a 21.3% rank-one rate. GoodRx Care sits in the middle of the tracked set, ahead of Walgreens, PillPack, Honeybee Health, Optum, and Capsule on top-three rate, but behind Amazon Pharmacy, CVS Pharmacy, Cost Plus Drugs, and Express Scripts.

Average recommended rank covers rank-eligible recommendations only.

GoodRx Care's 9.18% top-three rate places it fifth of ten, and its 2.95% rank-one rate places it third, behind Amazon Pharmacy and CVS Pharmacy. Its average recommended rank of 2.76 is the fourth-best in the set, ahead of CVS Pharmacy and Walgreens despite lower top-three volume. The table shows a brand with competitive mid-list placement and a rank-one rate that outperforms most of the field but remains far behind the category leader.

Prompt Evidence

Questions This Section Answers

• Which prompt produced GoodRx Care's strongest Copilot performance?
• What did the Perplexity and Gemini prompt results reveal about the brand's rank-one placements?

Copilot / Brand Recommendation Prompt: "What are the top 5 pharmacies?" Result: GoodRx Care recorded its strongest platform performance on Copilot, with a 29.2% top-three rate and a 12.5% rank-one rate across 72 observations.

Perplexity / Brand Recommendation Prompt: "Which is the most reliable online pharmacy?" Result: GoodRx Care holds 5 valid recommendations and zero rank-one placements on Perplexity across 61 observations, a 6.6% top-three rate.

Google AI Mode / Brand Recommendation Prompt: "What is the best mail-order pharmacy?" Result: GoodRx Care recorded 24 valid recommendations and 2 rank-one placements on Google AI Mode, a 7.5% top-three rate across 173 observations.

ChatGPT / Brand Recommendation Prompt: "Can Adderall be delivered by mail?" Result: GoodRx Care holds 7 valid recommendations and 2 rank-one placements on ChatGPT, a 6.8% top-three rate across 74 observations.

What CiteWorks Studio Would Do Next

Phase 1: AI Market Discovery Audit Map the prompt-level dynamics behind GoodRx Care's 16.5% coverage and 3.0% rank-one rate, isolating which prompts produce mid-list placement and which produce first-position recommendations.

Phase 2: Recommendation Readiness Plan Prioritize the Copilot and Google AI Mode surfaces where the brand already holds recommendation coverage, and define the specific prompt clusters where rank-one conversion is achievable.

Phase 3: Owned Answer Layer Buildout Strengthen the brand's owned pages around the discovery, comparison, and reliability questions that appear in the benchmark's prompt set, so AI systems have a clear, retrievable answer layer to draw from.

Phase 4: Citation / Authority Layer Development Develop the public evidence layer, including third-party references, comparison sources, and category authorities, that AI systems appear to retrieve when forming pharmacy recommendations.

Phase 5: Monthly AI Visibility and Recommendation Tracking Track coverage, top-three rate, rank-one rate, and sentiment month over month across all six surfaces, with particular attention to Perplexity and Gemini where the brand's footprint is thinnest.

Why This Matters

GoodRx Care's September 2026 entry shows a brand that AI systems are willing to reference and frame favorably, but not yet willing to name first. That distinction matters because rank-one placement carries the default-choice weight in AI-driven pharmacy selection. A buyer who asks an AI system for the best online pharmacy and receives a shortlist will often act on the first option named. GoodRx Care's 16.5% coverage and 3.0% rank-one rate mean the brand is present in the conversation but rarely the answer.

The next move is targeted correction of the prompt, page, and citation layers that produce first-position recommendations. The brand's Copilot performance shows that rank-one placement is achievable on at least one surface. Extending that pattern across Google AI Mode, Perplexity, and Gemini requires understanding which prompts drive first-position placement on Copilot and which public sources AI systems retrieve when forming those answers.

Core Metrics

Sentiment Score

Questions This Section Answers

• What is GoodRx Care's September 2026 sentiment score and how is it calculated?
• Why is raw mention count misleading without classified sentiment?

Sentiment Score = (positive mentions × 1 + neutral mentions × 0 + negative mentions × -1) / total mentions

GoodRx Care's September 2026 sentiment score is 0.7650, calculated from 155 positive mentions, 43 neutral mentions, and 2 negative mentions across 200 total mentions.

This matters because unclassified mention counts are misleading. A brand that appears in 200 AI answers but is framed negatively, or listed only as a comparison anchor, is not in the same position as a brand whose mentions are overwhelmingly positive recommendations. Share of voice is a diagnostic metric, not a business KPI. A positive recommendation, a neutral reference, a cautionary mention, and a competitor-displaced mention are not equal, and counting all mentions as wins is bad measurement. Classified sentiment is required before interpreting AI visibility, because it separates the brand's framing quality from its raw presence.

Sentiment by Platform

Questions This Section Answers

• On which platform does GoodRx Care have the strongest framing quality?
• Which platform shows the brand present as context rather than as a recommendation?

Methodology

1. This report is a benchmark-based analysis of GoodRx Care's position in the LLM Authority Index AI Market Discovery Index for Online Pharmacies, reporting month September 2026.
2. The reporting window covers the September 2026 benchmark run, with July 2026 and August 2026 figures used for movement comparison where available.
3. Six AI platforms were tracked: ChatGPT, Copilot, Gemini, Perplexity, Google AI Overviews, and Google AI Mode.
4. The September 2026 benchmark is based on 643 qualified observations, drawn from an underlying collection of 800 prompt-surface observations and 559 unique questions.
5. The tracked competitor universe includes ten brands: Amazon Pharmacy, Capsule, Cost Plus Drugs, CVS Pharmacy, Express Scripts, GoodRx Care, Honeybee Health, Optum, PillPack (Amazon Pharmacy), and Walgreens.
6. Three public high-intent clusters are defined: Best Online Pharmacy Discovery & Evaluation, Online Pharmacy Comparison & Alternatives, and Online Pharmacy Pricing, Costs & Savings. All 643 qualified September observations fell into the Brand Recommendation class, and the Pricing & Value and Multi-Brand Comparison clusters carry zero qualified observations in the public series.
7. Stage 0 extraction retains the query, AI surface, answer, brand outcome, recommendation placement, sentiment, and, where exposed, citations or attributable evidence sources.
8. A mention is counted when a tracked brand appears in a qualified AI response, regardless of whether it is recommended.
9. A valid recommendation is counted when a brand appears in a recommendation-shaped answer and the dataset marks it as a valid recommendation. Negative, neutral, cautionary, comparison-anchor, and listed-only mentions are not counted as valid recommendations.
10. Brand tracking changed in September 2026: GoodRx and Optum Rx, tracked in July and August, no longer appear as separately tracked brands, and GoodRx Care and Optum entered tracking. The parent brands' historical series are not directly comparable to the new entities' current coverage.
11. Ranking interpretation: top-three rate is the share of qualified observations where the brand appears among the top three recommended options. Rank-one rate is the share where the brand is the first recommendation. Average recommended rank covers rank-eligible recommendations only.
12. Limitations: this public benchmark does not measure market share, attributable sales, every possible AI response, organic-search ranking, social mention volume, private or sponsored channels, or causality from a metric movement alone. Source presence is evidence about the information environment and is not automatically proof that the source caused the recommendation.

See Where AI Is Recommending Your Brand

The public benchmark shows where GoodRx Care stands in AI-generated pharmacy recommendations. A company-level AI visibility audit maps the prompt, surface, competitor, ranking, sentiment, and evidence-source patterns behind those numbers into a prioritized strategy for competing in AI-driven pharmacy discovery.